RG1662

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for RG1662, covering 2015-03-03 to 2017-10-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) [Phase 2]